MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 208 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $356 | -79.2% | 1,269 | -82.9% | 0.01% | -84.0% |
| Q2 2023 | $1,712 | -28.4% | 7,411 | -24.9% | 0.08% | -33.6% |
| Q1 2023 | $2,390 | -4.8% | 9,867 | +14.1% | 0.11% | -18.7% |
| Q4 2022 | $2,511 | -99.6% | 8,650 | -6.4% | 0.14% | +286.1% |
| Q3 2022 | $601,000 | +74.2% | 9,240 | +91.6% | 0.04% | +38.5% |
| Q2 2022 | $345,000 | -27.1% | 4,823 | 0.0% | 0.03% | -16.1% |
| Q1 2022 | $473,000 | +3.3% | 4,823 | -10.8% | 0.03% | -45.6% |
| Q4 2021 | $458,000 | – | 5,409 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |